Acute poisonings treated in hospitals in Oslo: A one-year prospective study (II): Clinical outcome

Clinical Toxicology

Volumn 46, Issue 1, 2008, Pages 42-49

  Heyerdahl, Fridtjof ^a   Bjornas, Maria ^a,b   Hovda, Knut Erik ^a   Skog, Karina ^c   Opdahl, Anders ^d   Wium, Cecilie ^e   Ekeberg, Oivind ^a,b   Jacobsen, Dag ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d DIAKONHJEMMET HOSPITAL   (Norway)

^e LOVISENBERG DIAKONALE HOSPITAL   (Norway)

Author keywords

Acute poisoning; Alcohol; Consciousness; Drug abuse; Mortality; Toxicology

Indexed keywords

4 METHYLPYRAZOLE; ACETYLCYSTEINE; ACTIVATED CARBON; ANTIDOTE; DEFEROXAMINE; FLUMAZENIL; NALOXONE; PHYSOSTIGMINE; VITAMIN K GROUP;

ADOLESCENT; ADULT; ALCOHOL ABUSE; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DAMAGE; CARDIOPULMONARY BYPASS; COMATOSE PATIENT; CONVULSION; CROSS-SECTIONAL STUDY; DRUG ABUSE; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; HYPOTENSION; HYPOTHERMIA; INTOXICATION; INTUBATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PNEUMONIA; PROSPECTIVE STUDY; RESPIRATION DEPRESSION; RESUSCITATION; RHABDOMYOLYSIS; STOMACH LAVAGE; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDOTES; COMA; CROSS-SECTIONAL STUDIES; ETHANOL; FEMALE; FLUMAZENIL; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NALOXONE; NORWAY; POISONING; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STREET DRUGS; TREATMENT OUTCOME;

EID: 37649024681     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650701210048     Document Type: Article

References (29)

1. Jones AL, Volans G. Management of self poisoning. BMJ 1999; 319:1414-1417.
2. Jacobsen D, Frederichsen PS, Knutsen KM, Sorum Y, Talseth T, Odegaard OR. Clinical course in acute self-poisonings: A prospective study of 1125 consecutively hospitalised adults. Hum Toxicol 1984; 3:107-116.
3. Rygnestad T, Fagerhaug O. Acute deliberate self-poisonings in the area of Trondheim, 1978-2002. Tidsskr Nor Laegeforen 2004; 124:2736-2739.
4. Townsend E, Hawton K, Harriss L, Bale E, Bond A. Substances used in deliberate self-poisoning 1985-1997: Trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol 2001; 36:228-234.
5. Staikowsky F, Theil F, Mercadier P, Candella S, Benais JP. Change in profile of acute self drug-poisonings over a 10-year period. Hum Exp Toxicol 2004; 23:507-511.
6. Lockhart SP, Baron JH. Changing ethnic and social characteristics of patients admitted for self-poisoning in West London during 1971/2 and 1983/4. J R Soc Med 1987; 80:145-148.
7. Jacobsen D, Frederichsen PS, Knutsen KM, Sorum Y, Talseth T, Odegaard OR. A prospective study of 1212 cases of acute poisoning: General epidemiology. Hum Toxicol 1984; 3:93-106.
8. Bateman DN, Bain M, Gorman D, Murphy D. Changes in paracetamol, antidepressants and opioid poisoning in Scotland during the 1990s. QJM 2003; 96:125-132.
9. Burillo-Putze G, Munne P, Duenas A, Pinillos MA, Naveiro JM, Cobo J, Alonso J. National multicentre study of acute intoxication in emergency departments of Spain. Eur J Emerg Med 2003; 10:101-104.
10. Van Sassenbroeck DK, Calle PA, Rousseau FM, Verstraete AG, Belpaire FM, Monsieurs KG, Haentjens R, Allonsius J, Van BJ, Haenen W, Buylaert WA. Medical problems related to recreational drug use at nocturnal dance parties. Eur J Emerg Med 2003; 10:302-308.
11. Miro O, Nogue S, Espinosa G, To-Figueras J, Sanchez M. Trends in illicit drug emergencies: The emerging role of gamma-hydroxybutyrate. J Toxicol Clin Toxicol 2002; 40:129-135.
12. Snead OC, III, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med 2005; 352:2721-2732.
13. Sheen CL, Dillon JF, Bateman DN, Simpson KJ, Macdonald TM. Paracetamol toxicity: Epidemiology, prevention and costs to the healthcare system. QJM 2002; 95:609-619.
14. D'Mello DA, Finkbeiner DS, Kocher KN. The cost of antidepressant overdose. Gen Hosp Psychiatry 1995; 17:454-455.
15. Hovda KE, Bjornaas MA, Skog K, Opdahl A, Drottning P, Ekeberg O, Jacobsen D. Acute poisonings treated in hospital in Oslo: A one-year prospective study (I): Pattern of poisoning. clin Toxicol 2007.
16. Buajordet I, Naess AC, Jacobsen D, Brors O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med 2004; 11:19-23.
17. Hatzitolios AI, Sion ML, Eleftheriadis NP, Toulis E, Efstratiadis G, Vartzopoulos D, Ziakas AG. Parasuicidal poisoning treated in a Greek medical ward: epidemiology and clinical experience. Hum Exp Toxicol 2001; 20:611-617.
18. Cienki JJ, Burkhart KK, Donovan JW. Zopiclone overdose responsive to flumazenil. Clin Toxicol 2005; 43:385-386.
19. Barnett R, Grace M, Boothe P, Latozek K, Neal C, Legatt D, Finegan BA. Flumazenil in drug overdose: Randomized, placebo-controlled study to assess cost effectiveness. Crit Care Med 1999; 27:78-81.
20. Longmire AW, Seger DL. Topics in clinical pharmacology: Flumazenil, a benzodiazepine antagonist. Am J Med Sci 1993; 306:49-52.
21. Weinbroum A, Rudick V, Sorkine P, Nevo Y, Halpern P, Geller E, Niv D. Use of flumazenil in the treatment of drug overdose: A double-blind and open clinical study in 110 patients. Crit Care Med 1996; 24:199-206.
22. Dargan PI, Jones AL. Management of paracetamol poisoning. Trends Pharmacol Sci 2003; 24:154-157.
23. Newton RW. Physostigmine salicylate in the treatment of tricyclic antidepressant overdosage. JAMA 1975; 231:941-943.
24. Vale JA. Position statement: Gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:711-719.
25. Lamminpaa A, Riihimaki V, Vilska J. Hospitalizations due to poisonings in Finland. J Clin Epidemiol 1993; 46:47-55.
26. Tagwireyi D, Ball DE, Nhachi CF. Poisoning in Zimbabwe: A survey of eight major referral hospitals. J Appl Toxicol 2002; 22:99-105.
27. Bruyndonckx RB, Meulemans AI, Sabbe MB, Kumar AA, Delooz HH. Fatal intentional poisoning cases admitted to the University Hospitals of Leuven, Belgium from 1993 to 1996. Eur J Emerg Med 2002; 9:238-243.
28. Nice A, Leikin JB, Maturen A, Madsen-Konczyk LJ, Zell M, Hryhorczuk DO. Toxidrome recognition to improve efficiency of emergency urine drug screens. Ann Emerg Med 1988; 17:676-680.
29. Bjornaas MA, Hovda KE, Mikalsen H, Andrew E, Rudberg N, Ekeberg O, Jacobsen D. Clinical vs. laboratory identification of drugs of abuse in patients admitted for acute poisoning. Clin Toxicol 2006; 44:127-134.